GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 04/07/2008
PIL Zinnat Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/07/2008 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 22/02/2007 and displayed until 04/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 23/05/2006 and displayed until 22/02/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 14/11/2005 and displayed until 23/05/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 22/10/2003 and displayed until 14/11/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 21/11/2002 and displayed until 22/10/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 02/05/2002 and displayed until 21/11/2002
Reasons for adding or updating:
  • New PIL for new product
Updated on 22/03/2001 and displayed until 02/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   cefuroxime
   cefuroxime axetil